InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Millstone post# 6138

Wednesday, 11/01/2017 8:41:56 PM

Wednesday, November 01, 2017 8:41:56 PM

Post# of 8449
Yes - that os good news but look at the IND submission timeline - H1 2019 is too far off

“... We appreciate FDA's helpful guidance and look forward to continuing to work with the FDA toward an IND submission, which based on our current development plans, we now expect to submit during the first half of 2019," said Dr. J. Paul Waymack, Chairman of Kitov's Board and Chief Medical Officer. ..”